Cargando…

Even High Doses of Oral Cannabidiol Do Not Cause THC-Like Effects in Humans: Comment on Merrick et al. Cannabis and Cannabinoid Research 2016;1(1):102–112; DOI: 10.1089/can.2015.0004

This short communication examines the question whether the experimental data presented in a study by Merrick et al. are of clinical relevance. These authors found that cannabidiol (CBD), a major cannabinoid of the cannabis plant devoid of psychotropic effects and of great interest for therapeutic us...

Descripción completa

Detalles Bibliográficos
Autores principales:	Grotenhermen, Franjo, Russo, Ethan, Zuardi, Antonio Waldo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Mary Ann Liebert, Inc. 2017
Materias:	Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5531368/ https://www.ncbi.nlm.nih.gov/pubmed/28861499 http://dx.doi.org/10.1089/can.2016.0036

Ejemplares similares

Conversion of Cannabidiol Following Oral Administration: Authors' Response to Grotenhermen et al. DOI: 10.1089/can.2016.0036
por: Bonn-Miller, Marcel O., et al.
Publicado: (2017)

Response to Morita et al., Re: Continuous Deep Sedation (DOI: 10.1089/pmr.2021.0058)
por: Broeckaert, Bert
Publicado: (2022)

A Conversion of Oral Cannabidiol to Delta9-Tetrahydrocannabinol Seems Not to Occur in Humans
por: Nahler, Gerhard, et al.
Publicado: (2017)

Response to Morita et al., Re: Defining “Continuous Deep Sedation” Using Treatment Protocol (DOI: 10.1089/pmr.2021.0058)
por: Twycross, Robert G.
Publicado: (2022)

Response to Tark et al. (doi: 10.1089/jpm.2018.0626): Variations in Physician Orders for Life-Sustaining Treatment Program across the Nation: Environmental Scan
por: Jimenez, Valerie M., et al.
Publicado: (2019)

Response to Pairojkul et al. Integration of Specialist Palliative Care into Tertiary Hospitals: A Multicenter Point Prevalence Survey from Thailand (DOI: 10.1089/pmr.2021.0003)
por: Mungmunpuntipatip, Rujittika, et al.
Publicado: (2022)

An Update on Safety and Side Effects of Cannabidiol: A Review of Clinical Data and Relevant Animal Studies
por: Iffland, Kerstin, et al.
Publicado: (2017)

Dr. Myra K. Merrick
Publicado: (1899)

Articulating the Elephant Man: Joseph Merrick and his interpreters
por: Shortland, Michael
Publicado: (1993)

Δ9-THC Intoxication by Cannabidiol-Enriched Cannabis Extract in Two Children with Refractory Epilepsy: Full Remission after Switching to Purified Cannabidiol
por: Crippa, José A. S., et al.
Publicado: (2016)

Does Cannabidiol Protect Against Adverse Psychological Effects of THC?
por: Niesink, Raymond J. M., et al.
Publicado: (2013)

17.4 POSSIBLE MECHANISMS INVOLVED IN THE ANTIPSYCHOTIC EFFECTS OF CANNABIDIOL (CBD)
por: Crippa, Jose Alexandre, et al.
Publicado: (2018)

Are adverse effects of cannabidiol (CBD) products caused by tetrahydrocannabinol (THC) contamination?
por: Lachenmeier, Dirk W., et al.
Publicado: (2023)

Corrigendum to Bae et al. J Cachexia Sarcopenia Muscle 11, 1089–1103, 2020. doi: 10.1002/jcsm.12563
Publicado: (2020)

Re: Aminsharifi et al., Major Complications and Adverse Events Related to the Injection of the SpaceOAR Hydrogel System Before Radiotherapy for Prostate Cancer: Review of the Manufacturer and User Facility Device Experience Database (From: Aminsharifi A, Kotamarti S, Silver D, et al., J Endourol 2019;33:868–871; DOI: 10.1089/end.2019.0431)
por: Babayan, Richard K., et al.
Publicado: (2020)

Confidences galantes, MET CD 1089/

1089 and all that: a journey into mathematics
por: Acheson, David
Publicado: (2002)

Efficacy of MAP0004 in treating severe migraine
por: Kori, S, et al.
Publicado: (2013)

Cannabis containing equivalent concentrations of delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD) induces less state anxiety than THC-dominant cannabis
por: Hutten, Nadia R. P. W., et al.
Publicado: (2022)

A protocol for the delivery of cannabidiol (CBD) and combined CBD and ∆(9)-tetrahydrocannabinol (THC) by vaporisation
por: Solowij, Nadia, et al.
Publicado: (2014)

The Dark Side of Cannabidiol: The Unanticipated Social and Clinical Implications of Synthetic Δ(8)-THC
por: Geci, Michael, et al.
Publicado: (2023)

Conversion of Cannabidiol (CBD) into Psychotropic Cannabinoids Including Tetrahydrocannabinol (THC): A Controversy in the Scientific Literature
por: Golombek, Patricia, et al.
Publicado: (2020)

The Effect of Orally Administered Δ9-Tetrahydrocannabinol (THC) and Cannabidiol (CBD) on Obesity Parameters in Mice
por: Eitan, Adi, et al.
Publicado: (2023)

Evaluation of Serum Cytokines Levels and the Role of Cannabidiol Treatment in Animal Model of Asthma
por: Vuolo, Francieli, et al.
Publicado: (2015)

Cannabidiol (CBD) content in vaporized cannabis does not prevent tetrahydrocannabinol (THC)-induced impairment of driving and cognition
por: Arkell, Thomas R., et al.
Publicado: (2019)

The anxiolytic effect of cannabidiol depends on the nature of the trauma when patients with post-traumatic stress disorder recall their trigger event
por: Bolsoni, Lívia Maria, et al.
Publicado: (2022)

Evaluation of the role of the cannabidiol system in an animal model of ischemia/reperfusion kidney injury
por: Soares, Rodrigo Zon, et al.
Publicado: (2015)

Is Cannabidiol During Neurodevelopment a Promising Therapy for Schizophrenia and Autism Spectrum Disorders?
por: Loss, Cássio Morais, et al.
Publicado: (2021)

Real world experience of patients with amyotrophic lateral sclerosis (ALS) in the treatment of spasticity using tetrahydrocannabinol:cannabidiol (THC:CBD)
por: Meyer, Thomas, et al.
Publicado: (2019)

Proteome-Wide Profiling Using Sample Multiplexing of a Human Cell Line Treated with Cannabidiol (CBD) and Tetrahydrocannabinol (THC)
por: Abyadeh, Morteza, et al.
Publicado: (2023)

Antiapoptotic effects of cannabidiol in an experimental model of cognitive decline induced by brain iron overload
por: da Silva, Vanessa Kappel, et al.
Publicado: (2018)

First experience with BAK-free travoprost 0.004% in topical glaucoma medication
por: Gado, Ahmed Salah, et al.
Publicado: (2012)

Rv0004 is a new essential member of the mycobacterial DNA replication machinery
por: Mann, Katherine M., et al.
Publicado: (2017)

Enzyme systems involved in glucosinolate metabolism in Companilactobacillus farciminis KB1089
por: Watanabe, Hiroko, et al.
Publicado: (2021)

Motor neuron development in zebrafish is altered by brief (5-hr) exposures to THC (∆(9)-tetrahydrocannabinol) or CBD (cannabidiol) during gastrulation
por: Ahmed, Kazi T., et al.
Publicado: (2018)

Pooled results of two randomized clinical trials comparing the efficacy and safety of travoprost 0.004%/timolol 0.5% in fixed combination versus concomitant travoprost 0.004% and timolol 0.5%
por: Gross, Ronald L, et al.
Publicado: (2007)

Sustained intraocular pressure reduction throughout the day with travoprost ophthalmic solution 0.004%
por: Dubiner, Harvey B, et al.
Publicado: (2012)

MAP0004 provided consistent migraine pain relief even after repeated administration
por: Kori, S, et al.
Publicado: (2013)

1089. Analytical Performance of an Ultrasensitive Immunoassay for Detection of Clostridium difficile Toxins in Stool
por: Bartolome, Amelita, et al.
Publicado: (2018)

Delta-8-THC: Delta-9-THC’s nicer younger sibling?
por: Kruger, Jessica S., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_8m6o3qbfp4goh6pmja741riv8r